Brand Cialis for sale – who is a developer of the original medicament?

Brand Cialis is one of the most popular medical remedies for treating erectile dysfunction. It is the only product of its kind, which has a prolonged effect – it acts for 36 hours! Of course, only a company with a great name and vast financial resources could develop such a drug. This company is Eli Lilly. In this article, you will learn the basic facts about the developer of brand Cialis.

History of Cialis developer and main features

Eli Lilly was established in the middle of 1870’s and has almost 150 years’ experience in the pharmaceutical market. The headquarters of the company is located in Indianapolis city. Its products are offered in more than 25 countries in the whole world. As of 2017, the President of the firm is John C. Lechleiter. Now the firm is a real world pharmaceutical giant. It has more than 41 000 employees in multiple countries. Approximately 9000 Lilly employees are engaged in researching and developing the area.

Key activities of Eli Lilly

Global business spheres of the firm are:

I) Bio-Medicines (production of drugs for curing vascular & heart ailments, as well as neurological, urological and autoimmune diseases), this business sphere includes production of brand Cialis for sale;
II) Lilly Diabetes (the firm has developed the first insulin for commercial use in the world);
III) Elanco Animal Health (the firm manufactures food supplements for animals);
IV) Emerging Markets (starting multiple manufacturing projects in such countries as Russia and Turkey);
V) Lilly Oncology (the company is famous for the fact that it produces innovative drugs for the treatment of cancer).

Official Cialis sale volumes

Eli Lilly offers Brand Cialis for sale in the USA, Canada, EU states and some other countries. In the US market, the medicament is included in the list of TOP-50 best selling medical remedies according to statistical data. It brought the producer approximately $2.3 billion in 2015. It is interesting, that Cialis sale volumes have increased for the recent years. For instance, in 2012 the medicament generated almost $2 billion, in 2013 – more that $2.1 billion. During 2014, it brought Eli Lilly more than $2.3 billion.

Lilly’s position towards producing generic variants of medical remedies

The company says that in its opinion, generic drugs are very important for the pharmaceutical market. However, it is necessary for the generic drugs to be monitored by properly specialized regulatory agencies. This control must ensure the safety of drugs and their effectiveness. The company is ready to cooperate with generic manufacturers after the expiration of patent protection of original medical remedies.